Surfactant Application During Spontaneous Breathing With Continuous Positive Airway Pressure (CPAP) in Premature Infants < 27 Weeks

NCT00751959 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

213

Enrollment

OTHER

Sponsor class

Conditions

Respiratory Distress Syndrome, Newborn

Interventions

DRUG: Curosurf
DRUG: Curosurf

Sponsor

University of Cologne

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]